p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms
Aims. The aim of this study was to establish p53 immunohistochemistry (IHC) patterns to predict TP53 mutations in gastrointestinal neuroendocrine neoplasms (GI-NENs) and to determine whether p53 IHC patterns could be used for the differential diagnosis of neuroendocrine neoplasms. Methods. TP53 gene...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2021/2510195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849467835957379072 |
|---|---|
| author | Junjie Li Jing Wang Dan Su Xiu Nie Yueping Liu Lianghong Teng Junyi Pang Huanwen Wu Zhiyong Liang |
| author_facet | Junjie Li Jing Wang Dan Su Xiu Nie Yueping Liu Lianghong Teng Junyi Pang Huanwen Wu Zhiyong Liang |
| author_sort | Junjie Li |
| collection | DOAJ |
| description | Aims. The aim of this study was to establish p53 immunohistochemistry (IHC) patterns to predict TP53 mutations in gastrointestinal neuroendocrine neoplasms (GI-NENs) and to determine whether p53 IHC patterns could be used for the differential diagnosis of neuroendocrine neoplasms. Methods. TP53 gene sequencing and p53 IHC were performed on formalin-fixed paraffin-embedded (FFPE) tissue samples from 92 patients diagnosed with GI-NENs from five medical centers. Results. The cohort included 35 well-differentiated neuroendocrine tumors and 57 poorly differentiated neuroendocrine carcinomas. Gene sequencing revealed 38 wild-type TP53 and 54 TP53 mutations. p53 expression was interpreted as follows: pattern A, p53 was absent from all tumor cells; pattern B, scattered and weak p53 expression in 1-20% of tumor cells; and pattern C was subclassified as pattern C1: variable p53 staining intensity in 21-60% of tumor cells and tumor cell nests with focal strong positive p53 staining and pattern C2: strong p53 staining in more than 60% of tumor cells. p53 IHC patterns were evaluated as a binary classifier where pattern B predicted wild-type TP53, and patterns A and C predicted TP53 mutations. The sensitivity, specificity, and overall accuracy of this binary classification to predict TP53 status were 0.963, 0.868, and 0.924, respectively. p53 IHC patterns were also correlated with TP53 mutation types. Most cases with pattern A harboured loss-of-function (LOF) mutations, whereas patterns B and C tended to indicate wild-type TP53 and gain-of-function (GOF) mutations, respectively. Furthermore, most of the well-differentiated NETs showed pattern B, whereas pattern C2 was more common in poorly differentiated NECs. Finally, staining interpretation between different observers also yielded high reproducibility. Conclusions. p53 IHC patterns may be used as predictors of TP53 gene mutations and therefore could be potential surrogate markers for TP53 mutations in GI-NENs and could distinguish between well-differentiated NETs and poorly differentiated NECs. |
| format | Article |
| id | doaj-art-e6cc4ad66e984d81ab38d66ea42766e9 |
| institution | Kabale University |
| issn | 1687-630X |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-e6cc4ad66e984d81ab38d66ea42766e92025-08-20T03:26:03ZengWileyGastroenterology Research and Practice1687-630X2021-01-01202110.1155/2021/2510195p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine NeoplasmsJunjie Li0Jing Wang1Dan Su2Xiu Nie3Yueping Liu4Lianghong Teng5Junyi Pang6Huanwen Wu7Zhiyong Liang8Department of PathologyDepartment of PathologyDepartment of PathologyDepartment of PathologyDepartment of PathologyDepartment of PathologyDepartment of PathologyDepartment of PathologyDepartment of PathologyAims. The aim of this study was to establish p53 immunohistochemistry (IHC) patterns to predict TP53 mutations in gastrointestinal neuroendocrine neoplasms (GI-NENs) and to determine whether p53 IHC patterns could be used for the differential diagnosis of neuroendocrine neoplasms. Methods. TP53 gene sequencing and p53 IHC were performed on formalin-fixed paraffin-embedded (FFPE) tissue samples from 92 patients diagnosed with GI-NENs from five medical centers. Results. The cohort included 35 well-differentiated neuroendocrine tumors and 57 poorly differentiated neuroendocrine carcinomas. Gene sequencing revealed 38 wild-type TP53 and 54 TP53 mutations. p53 expression was interpreted as follows: pattern A, p53 was absent from all tumor cells; pattern B, scattered and weak p53 expression in 1-20% of tumor cells; and pattern C was subclassified as pattern C1: variable p53 staining intensity in 21-60% of tumor cells and tumor cell nests with focal strong positive p53 staining and pattern C2: strong p53 staining in more than 60% of tumor cells. p53 IHC patterns were evaluated as a binary classifier where pattern B predicted wild-type TP53, and patterns A and C predicted TP53 mutations. The sensitivity, specificity, and overall accuracy of this binary classification to predict TP53 status were 0.963, 0.868, and 0.924, respectively. p53 IHC patterns were also correlated with TP53 mutation types. Most cases with pattern A harboured loss-of-function (LOF) mutations, whereas patterns B and C tended to indicate wild-type TP53 and gain-of-function (GOF) mutations, respectively. Furthermore, most of the well-differentiated NETs showed pattern B, whereas pattern C2 was more common in poorly differentiated NECs. Finally, staining interpretation between different observers also yielded high reproducibility. Conclusions. p53 IHC patterns may be used as predictors of TP53 gene mutations and therefore could be potential surrogate markers for TP53 mutations in GI-NENs and could distinguish between well-differentiated NETs and poorly differentiated NECs.http://dx.doi.org/10.1155/2021/2510195 |
| spellingShingle | Junjie Li Jing Wang Dan Su Xiu Nie Yueping Liu Lianghong Teng Junyi Pang Huanwen Wu Zhiyong Liang p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms Gastroenterology Research and Practice |
| title | p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms |
| title_full | p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms |
| title_fullStr | p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms |
| title_full_unstemmed | p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms |
| title_short | p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms |
| title_sort | p53 immunohistochemistry patterns are surrogate biomarkers for tp53 mutations in gastrointestinal neuroendocrine neoplasms |
| url | http://dx.doi.org/10.1155/2021/2510195 |
| work_keys_str_mv | AT junjieli p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT jingwang p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT dansu p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT xiunie p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT yuepingliu p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT lianghongteng p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT junyipang p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT huanwenwu p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms AT zhiyongliang p53immunohistochemistrypatternsaresurrogatebiomarkersfortp53mutationsingastrointestinalneuroendocrineneoplasms |